Generics Lowering Part D Rx Costs, CMS Reports

Published Online: Tuesday, August 1, 2006
p align=justify> Although critics of the new Medicare Part D drug benefit are pushing for changes in the program to lower costs to seniors, officials at the Centers for Medicare & Medicaid Services (CMS) contend that the program is already cutting prescription costs far more than originally expected.

According to CMS, strong competition among competing Part D prescription drug plans has enabled Medicare patients to see "deep discounts on their drugs at their local pharmacies," with much of the savings coming as a result of generic drugs. "In many cases, beneficiaries are using the unprecedented price information provided by Medicare to get much larger savings by switching to lower-cost drugs," CMS said. "Many beneficiaries?have switched to generic drugs, obtaining even deeper discounts on their drug costs."

Latest Articles
Mylan has announced the US launch of clozapine orally disintegrating tablets, 25 mg and 100 mg, the generic version of Jazz Pharmaceutical’s FazaClo.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about some safeguards pharmacists can implement.
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Latest Issues